Outcomes evaluated were local recurrence, distant recurrence, and survival.

结果采用局部复发，远处复发和生存率来评估。

youdao

Outcomes evaluated included local recurrence, distant recurrence, and cancer specific survival.

评价结果包括局部复发，远处复发，肿瘤特异性生存率。

youdao

Nether neither local nor distant recurrence had been found for a longest follow-up period of 18.6 months and a median follow-up period of 9.2 months.

术后随访时间最长18。6个月，中位平均随访时间为9。2个月，全组无局部复发和远处转移。

youdao